Rights and permissions
About this article
Cite this article
Test-and-treat strategy for latent TB potentially cost saving. Pharmacoecon. Outcomes News 393, 9 (2002). https://doi.org/10.1007/BF03280004
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280004